Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 31466

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DL-Homocysteine thiolactone is a derivative of DL-homocysteine (Item No. 30285).1 It inhibits the growth of B. campestris, L. sativa, and E. utilis roots when used at a concentration of 50 µM.2 DL-Homocysteine thiolactone (10 µM) decreases the maximum rate of left ventricular developed pressure, systolic left ventricular pressure, and coronary flow in isolated rat hearts.3 It induces arteriosclerotic plaque formation in rabbits when administered at a dose of 30 mg/kg for eight weeks.1 DL-Homocysteine thiolactone has also been used as a precursor in the synthesis of thiolactone-containing monomers for use in polymer-based formaldehyde-scavenging coatings.4
WARNING This product is not for human or veterinary use.
1. Homocysteine theory of arteriosclerosis. Atherosclerosis 22(2), 215-227 (1975).
2. Root-
3. Effects of DL-
4. Thiolactone-